Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 29, 2024Frontiers in NeurologyOpen Access

The interplay between gut microbiota and the brain-gut axis in Parkinson’s disease treatment

View Full Paper
Ask AI
Bookmark
Share

Authors

XJXi JiaHong Kong Baptist UniversityQWQin WangNorthwest Minzu UniversityMLMeilingzi LiuMudanjiang Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jia et al. (2024) studied this question.

synapsesocial.com/papers/68e67cc7b6db643587606e20https://doi.org/10.3389/fneur.2024.1415463
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162018 · 2,885 citations
  2. 2Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis2023 · 71 citations
  3. 31-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Induced Parkinson’s Disease in Mouse: Potential Association between Neurotransmitter Disturbance and Gut Microbiota Dysbiosis2020 · 51 citations
  4. 4Effect of Berberine Hydrochloride on the Diversity of Intestinal Flora in Parkinson’s Disease Patients2022 · 22 citations
  5. 5Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis2023 · 27 citations